Work

G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.149.149

Authors: Anna B. Halpern, Emily M. Huebner, Megan Othus, Bart L. Scott, Pamela S. Becker, Mary‐Elizabeth M. Percival, Paul C. Hendrie, Kelda M. Gardner, Sarah Buckley, Elihu H. Estey, Roland B. Walter

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2977426434

FWCI: 0.181

Cites:

Cited by: 1

Related to: 20